4 completed. 3 Not applicable, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
| Early Phase 1 | 1 | Completed 1 |
Follow Mikkel Christensen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes GIP, GLP-1, Saline - Type 1 Diabetes Mellitus | Not applicable | Completed | Mikkel Christensen | 10 | 2012-11-17 | 2017-06-23 |
| GIP and GLP-1 in Type 1 Diabetes GIP, GLP-1, Saline - Hypoglycemia | Not applicable | Completed | Mikkel Christensen | 10 | 2012-07-01 | 2015-07-13 |
| Liraglutide in Spinal Fluid Lumbar puncture - Liraglutide Blood-brain Transfer | Not applicable | Completed | Mikkel Christensen | 8 | 2012-01-01 | 2014-04-04 |
| GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes Glucose-dependent Insulinotropic polypeptide, saline - Type 2 Diabetes Mellitus | Early Phase 1 | Completed | Mikkel Christensen | 12 | 2011-05-01 | 2013-04-02 |
Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Hypoglycemia (1)
Sodium Chloride (3) · Glucagon-Like Peptide 1 (2) · Incretins (2) · Spinal Puncture (1)
Denmark (3)